Bone Biologics Corp
Bone Biologics Corp (BBLG): 61 pipeline candidates. Updated within the last hour.
BioSniper Score
2-factor signal · derived from public data
N/A
D/E 0.07 · 0% dilution
N/A
61 candidates
N/A
N/A
A transparent, data-derived signal for Bone Biologics Corpacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$2.5M
Cash
—
Quarterly Burn
$804K
Runway
—
Revenue
—
Pipeline (61 candidates)
Showing 10 of 61 candidates. Sign up for full pipeline.
Institutional Holdings
Source: SEC Form 13F · as of Dec 2025Institutional holders
3
Total value held
$32K
| Holder | Shares | Value |
|---|---|---|
| two sigma investments, lp | 11,083 | $16K |
| citadel advisors llc | 10,844 | $16K |
| bank of america corp /de/ | 14 | $20 |
Frequently asked questions
How many drug candidates are in Bone Biologics Corp's pipeline?
Bone Biologics Corp (BBLG) has 61 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is Bone Biologics Corp's market capitalization?
Bone Biologics Corp's market capitalization is approximately $2.5M.
Who is the CEO of Bone Biologics Corp?
Mr. Jeffrey Frelick is the chief executive officer of Bone Biologics Corp (BBLG).
Get the full picture on Bone Biologics Corp
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.